Anna Christiansen Hilliard , PA-C
Physician Assistant • Savannah, GA
1601 Abercorn St
Savannah, GA 314017521
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 7, 2022; this date does not establish years in practice.
-
Published CMS data list 125 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Alprazolam — 31 prescription fills, including refills.
- Clonazepam — 24 prescription fills, including refills.
- Gabapentin — 19 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 7 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 65% of clinicians listed under Physician Assistant in Savannah, GA (2024, 120 clinicians with data). Median for this group: 234. Middle half: 95 to 670.
Fewer Part D prescriptions than 60% of clinicians listed under Physician Assistant in Georgia (2024, 2,084 clinicians with data). Median for this group: 226. Middle half: 71 to 702.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 50 in 2023 to 125 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023–2024.
Practice Location & Contact Primary Location
1601 Abercorn St
Savannah, GA 314017521
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
169 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,253 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,838.65 across 83 records.
By nature of payment
- Food and Beverage: $1,838.65 across 83 records.
Reporting-company totals (3 largest of 16)
- ABBVIE INC.: $394.39 across 23 records.
- Axsome Therapeutics, Inc.: $318.79 across 13 records.
- Vanda Pharmaceuticals Inc.: $198.13 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2022
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Savannah and Georgia
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Physician Assistant in Savannah, GA (2024, 120 clinicians with data). Median for this group: 234. Middle half: 95 to 670.
Fewer Part D prescriptions than 60% of clinicians listed under Physician Assistant in Georgia (2024, 2,084 clinicians with data). Median for this group: 226. Middle half: 71 to 702.
Part D drug cost
A lower Part D drug cost than 65% of clinicians listed under Physician Assistant in Savannah, GA (2024, 120 clinicians with data). Median for this group: $3,401. Middle half: $606 to $61,982.
A lower Part D drug cost than 60% of clinicians listed under Physician Assistant in Georgia (2024, 2,084 clinicians with data). Median for this group: $4,253. Middle half: $612 to $75,670.
250 active clinicians are listed under Physician Assistant with a practice address in Savannah, GA (4,828 in Georgia).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Savannah
8.4% of these 250 clinicians have the CMS telehealth indicator.
59.2% of these 250 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 150% from 50 in 2023 to 125 in 2024.
- 2023: 50
- 2024: 125
-
30-day fills
30-day fills increased 225% from 52 in 2023 to 169 in 2024.
- 2023: 52
- 2024: 169
-
Part D drug cost
Part D drug cost went from $397 in 2023 to $1,253 in 2024.
- 2023: $397
- 2024: $1,253
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $609.72 in 2022 to $1,838.65 in 2025.
- 2022: $609.72
- 2023: $2,418.11
- 2024: $2,641.14
- 2025: $1,838.65
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 83 records totaling $1,838.65.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $33.87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $33.43 |
| Corium, LLC |
Food and Beverage
In-kind items and services
|
Azstarys | General | $33.16 |
| Neos Therapeutics, LP |
Food and Beverage
Cash or cash equivalent
|
EXXUA | General | $32.59 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $31.50 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $31.49 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $30.25 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $29.94 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $29.19 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $28.87 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $28.85 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY ASIMTUFII | General | $28.75 |
| Corium, LLC |
Food and Beverage
In-kind items and services
|
Azstarys | General | $28.00 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $27.50 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $27.41 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY ASIMTUFII | General | $27.21 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $26.79 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $26.65 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $26.63 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Sunosi | General | $26.60 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $26.30 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $25.97 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $25.93 |
| Corium, LLC |
Food and Beverage
In-kind items and services
|
Azstarys | General | $25.70 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $25.61 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Alprazolam | Alprazolam | 31 | 937 | $146.56 | 11 |
| Clonazepam | Clonazepam | 24 | 729 | $220.83 | 12 |
| Gabapentin | Gabapentin | 19 | 570 | $174.47 | — |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | 593 | $126.57 | — |
| Duloxetine Hcl | Duloxetine Hcl | 14 | 720 | $374.56 | — |
| Sertraline Hcl | Sertraline Hcl | 11 | 877 | $94.02 | — |
| Lorazepam | Lorazepam | 11 | 510 | $115.78 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-08-07NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Social Worker
Licensed Master Social Worker
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Physician Assistant
Physician Assistant (Certified)
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated August 07, 2022.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from August 2022 to November 2026.
NPI Administrative Meta
Other Physician Assistants in Savannah
- Andrea Yates, PA-C
- Sarah Rush, PA
- Clinton Brif
- Dawn Obrien, PA-C
- Lauren Morris, PA-C
- Anna Wallace, PA-C
Mailing Address
1712 Whitemarsh Way
Savannah, GA 314105230
Phone: 9126675141